1. Home
  2. BHST vs COYA Comparison

BHST vs COYA Comparison

Compare BHST & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.76

Market Cap

108.6M

Sector

N/A

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.79

Market Cap

126.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHST
COYA
Founded
2007
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.6M
126.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BHST
COYA
Price
$4.76
$4.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$14.00
$15.80
AVG Volume (30 Days)
31.9K
250.4K
Earning Date
03-30-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,720,000.00
$3,987,706.00
Revenue This Year
$116.40
$70.00
Revenue Next Year
$55.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.88
N/A
52 Week Low
$4.65
$3.94
52 Week High
$12.80
$8.29

Technical Indicators

Market Signals
Indicator
BHST
COYA
Relative Strength Index (RSI) 40.04 48.92
Support Level $4.82 $4.41
Resistance Level $5.03 $5.32
Average True Range (ATR) 0.29 0.30
MACD 0.01 0.06
Stochastic Oscillator 3.90 46.70

Price Performance

Historical Comparison
BHST
COYA

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Share on Social Networks: